Novartis has commenced a strategic review of its Sandoz division and will explore all options ranging from retaining the business to separation, according to Reuters.
According to the retailer’s just-released earnings report, its net income closed in on $300 million for the quarter, up from $284.5 million this time last year to reach $295.2 million.
The retailer reported that its fourth-quarter net sales rose 17.5% to $61.44 billion, just topping estimates of $61.41 billion, compared to $53.38 billion last year.
Rite Aid raised its full-year EBITDA guidance on the strength of its second-quarter results, which showed improved revenue and retail pharmacy strength even as it posted a net loss of $100.3 million.